Navega Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3210 Merryfield Row, San Diego, Californ...Phone Number
(928) 750-1629Website
www.navegatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Navega Therapeutics
Navega Therapeutics specializes in developing gene therapies aimed at chronic pain and precision pain management. The company utilizes advanced techniques such as zinc-finger and CRISPR-based epigenome regulation to create next-generation therapeutic solutions. Their intended clients include individuals suffering from chronic pain conditions seeking innovative treatment options. Based in San Diego, they are at the forefront of precision medicine in the field of pain management.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Navega Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Navega Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Navega Therapeutics had a recent Job posting/layoffs
Navega Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Navega Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Navega Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Navega Therapeutics is spiking on competitors!
Earning: See what the market has to say on Navega Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Navega Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Navega Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Navega Therapeutics
Compare insights from companies similar to Navega Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Navega Therapeutics
<$5M
1-10
Private
<$5M
2018
N/A
Company Profile Activity
Activity Insights
Navega Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Navega Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Navega Therapeutics.
Navega Therapeutics financials insights
Gather financial insights about Navega Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$72K
Navega Therapeutics Tech Stack
A closer look at the technologies used by Navega Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Funding
Project
received an award of $1,149,467 on September 8, 2023 by HHS NIH with an award end date of May 31, 2025. This award will support efforts focused on developing and optimizing epigenetic modulators to transiently inhibit NaV1.7 for effective, non-addictive chronic pain treatment, with improved specificity and long-lasting efficacy..
Product Development, Research & Development, Medical Research
Partnership
Research & Development, Clinical Systems, Intellectual Property
New Hire
Executive Move
Navega Therapeutics News & Media
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Navega Therapeutics, Inc., a biotechnology company developing epigenetic gene therapies, today announced an AAV9 production program agreement. As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Navega will have access to established contract development and manufacturing (CDMO) capabilities and advisory services to produce an adeno-associated virus (AAV)-based gene tNavega Therapeutics expands its Scientific Advisory Board with the addition of pain expert, Dr. Stephen Waxman.
SAN DIEGO, Aug. 24, 2021 /PRNewswire/ -- Navega Therapeutics, a San Diego-based biotechnology company developing epigenetic gene therapies, has announced that it is expanding its Scientific Advisory Board ("SAB") to include Dr. Stephen Waxman, MD, PhD. Dr. Waxman is the Bridget Flaherty...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Navega Therapeutics
Sign Up For FreeTo access detailed company insights
Navega Therapeutics specializes in developing gene therapies aimed at chronic pain and precision pain management. The company utilizes advanced techniques such as zinc-finger and CRISPR-based epigenome regulation to create next-generation therapeutic solutions. Their intended clients include individuals suffering from chronic pain conditions seekin... Read More
